Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous Marrow
- 14 June 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (24), 1557-1561
- https://doi.org/10.1056/nejm198406143102403
Abstract
Twenty-seven patients with malignant lymphoma in whom primary chemotherapy had failed and the prognosis was poor were treated with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. The median time to recovery of more than 500 neutrophils per microliter and more than 10,000 platelets per microliter was 18 and 24 days, respectively. Complete remission was achieved in 15 patients (56 per cent), five of whom were in continuous remission at this writing 19 to 71 months after transplantation without further therapy and one of whom was alive in a subsequent remission at 20 months. Fifteen patients died of lymphoma, three of interstitial pneumonitis, two of sepsis, and one of congestive heart failure. This experience shows that intensive therapy and autologous-marrow transplantation can produce prolonged remissions in patients with malignant lymphoma in whom conventional chemotherapy has failed. (N Engl J Med 1984; 310:1557–61.)Keywords
This publication has 16 references indexed in Scilit:
- Haematological reconstitution following high dose and supralethal chemo‐radiotherapy using stored, non‐cryopreserved autologous bone marrowBritish Journal of Haematology, 1983
- 4-Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graftBritish Journal of Haematology, 1982
- Alternating Drug Combinations in the Treatment of Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1982
- NONBACTERIAL NONFUNGAL PNEUMONIA FOLLOWING MARROW TRANSPLANTATION IN 100 IDENTICAL TWINSTransplantation, 1982
- Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's DiseaseAnnals of Internal Medicine, 1982
- Dose: A critical factor in cancer chemotherapyAmerican Journal Of Medicine, 1980
- Cobalt-60 total body irradiation dosimetry at 220 cm source-axis distanceInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958